No Data
Express News | Citius Oncology Inc - Receives Nasdaq Notice for Bid Price Non-Compliance - SEC Filing
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Wall Street Set to Open Lower Monday as Investors Gird for More Tariffs, Await Key Manufacturing Data
Top Premarket Gainers
Investors Brace for 'Liberation Day' as US Futures Trend Sharply Lower in Monday's Premarket
Trending Stocks Today | Citius Oncology Shoots up 84.96% Pre-Market
.. always does